211 related articles for article (PubMed ID: 28438823)
1. Association of human leukocyte antigen variants and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A meta-analysis.
Li X; Zhao Z; Sun SS
Am J Health Syst Pharm; 2017 May; 74(9):e183-e192. PubMed ID: 28438823
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
Somkrua R; Eickman EE; Saokaew S; Lohitnavy M; Chaiyakunapruk N
BMC Med Genet; 2011 Sep; 12():118. PubMed ID: 21906289
[TBL] [Abstract][Full Text] [Related]
3. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Ocular Manifestation and Genetic Association of Allopurinol-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in South Korea.
Lee HS; Ueta M; Kim MK; Seo KY; Sotozono C; Kinoshita S; Yoon KC
Cornea; 2016 Feb; 35(2):199-204. PubMed ID: 26655481
[TBL] [Abstract][Full Text] [Related]
5. HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.
Park HJ; Kim YJ; Kim DH; Kim J; Park KH; Park JW; Lee JH
Yonsei Med J; 2016 Jan; 57(1):118-26. PubMed ID: 26632391
[TBL] [Abstract][Full Text] [Related]
6. Association between the HLA-B alleles and carbamazepine-induced SJS/TEN: A meta-analysis.
Wang Q; Sun S; Xie M; Zhao K; Li X; Zhao Z
Epilepsy Res; 2017 Sep; 135():19-28. PubMed ID: 28618376
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.
Yu KH; Yu CY; Fang YF
Int J Rheum Dis; 2017 Sep; 20(9):1057-1071. PubMed ID: 28857441
[TBL] [Abstract][Full Text] [Related]
8. Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis.
Rashid M; Rajan AK; Chhabra M; Kashyap A; Chandran VP; Venkataraman R; Nair S; Thunga G
Seizure; 2022 Nov; 102():36-50. PubMed ID: 36183454
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine.
Park HJ; Kim SR; Leem DW; Moon IJ; Koh BS; Park KH; Park JW; Lee JH
Eur J Clin Pharmacol; 2015 Jan; 71(1):35-41. PubMed ID: 25327504
[TBL] [Abstract][Full Text] [Related]
10. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention.
Miliszewski MA; Kirchhof MG; Sikora S; Papp A; Dutz JP
Am J Med; 2016 Nov; 129(11):1221-1225. PubMed ID: 27086495
[TBL] [Abstract][Full Text] [Related]
11. A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
Tohkin M; Kaniwa N; Saito Y; Sugiyama E; Kurose K; Nishikawa J; Hasegawa R; Aihara M; Matsunaga K; Abe M; Furuya H; Takahashi Y; Ikeda H; Muramatsu M; Ueta M; Sotozono C; Kinoshita S; Ikezawa Z;
Pharmacogenomics J; 2013 Feb; 13(1):60-9. PubMed ID: 21912425
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.
Lu N; Rai SK; Terkeltaub R; Kim SC; Menendez ME; Choi HK
Semin Arthritis Rheum; 2016 Oct; 46(2):253-258. PubMed ID: 27217070
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis.
Zeng T; Long YS; Min FL; Liao WP; Shi YW
Int J Dermatol; 2015 Apr; 54(4):488-93. PubMed ID: 25428396
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
Tangamornsuksan W; Chaiyakunapruk N; Somkrua R; Lohitnavy M; Tassaneeyakul W
JAMA Dermatol; 2013 Sep; 149(9):1025-32. PubMed ID: 23884208
[TBL] [Abstract][Full Text] [Related]
15. Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.
Hershfield MS; Callaghan JT; Tassaneeyakul W; Mushiroda T; Thorn CF; Klein TE; Lee MT
Clin Pharmacol Ther; 2013 Feb; 93(2):153-8. PubMed ID: 23232549
[TBL] [Abstract][Full Text] [Related]
16. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
[TBL] [Abstract][Full Text] [Related]
17. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.
Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A
Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531
[TBL] [Abstract][Full Text] [Related]
18.
Ponzo MG; Miliszewski M; Kirchhof MG; Keown PA; Dutz JP
J Cutan Med Surg; 2019; 23(6):595-601. PubMed ID: 31378082
[TBL] [Abstract][Full Text] [Related]
19. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.
Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Sawada J; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R;
Pharmacogenomics; 2008 Nov; 9(11):1617-22. PubMed ID: 19018717
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population.
Chong HY; Lim YH; Prawjaeng J; Tassaneeyakul W; Mohamed Z; Chaiyakunapruk N
Pharmacogenet Genomics; 2018 Feb; 28(2):56-67. PubMed ID: 29176400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
